Clinical trial
Contribution of Inflammation and Neuronal Integrity Markers in Patients With First-episode Conversive Motor Disorder
NCT05305014 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Nīmes as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Contribution of Inflammation and Neuronal Integrity Markers in Patients With First-episode Conversive Motor Disorder
- Lead sponsor
- Centre Hospitalier Universitaire de Nīmes
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 1, 2022
- Completion date
- April 15, 2022
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.